Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein-Ba...
Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection
About this item
Full title
Author / Creator
FUJII, N , TAKENAKA, K , ISHIMARU, F , NIIYA, K , YOSHINO, T , HARADA, M , HIRAKI, A , MAEDA, Y , IKEDA, K , SHINAGAWA, K , ASHIBA, A , MUNEMASA, M , SUNAMI, K and HIRAMATSU, Y
Publisher
Basingstoke: Nature Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
Basingstoke: Nature Publishing Group
Subjects
More information
Scope and Contents
Contents
The prognosis of chronic active Epstein-Barr virus infection (CAEBV) is very poor. We describe a 24-year-old male with severe CAEBV who was treated with allogeneic peripheral blood stem cell transplantation (allo-PBSCT). On admission, EBER-1 in lymphocytes infiltrating the liver, EBV-DNA in peripheral blood mononuclear cells (PBMC) and monoclonal N...
Alternative Titles
Full title
Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_72356456
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_72356456
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/sj.bmt.1702600
